| SciPort RLP

2026 - 2029

"Assoziation zwischen Lebensalter und Genexpression beim frühen Mammakarzinom - prognostische und therapeutische Implikationen"

Univ.-Prof. Dr. Marcus

2026 - 2028

Biomarker study using aqueous humour of AMD patients with and without fibrosis (retrospective study)

Prof. Franz

2025 - 2027

PePCoM (Pectus Pain Comparative Management) bei operativer Korrektur von Brustwandfehlbildungen

Dr. Stephan

2025

A Phase 3 randomized, double-masked study comparing theefficacy of EYP-1901 against aflibercept

PD Dr. Dr. Katrin

2025

R3918-AMD-2326

PD Dr. Dr. Katrin

2025

A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Active, Non-Infectious Intermediate-, Posterior-, and Panuveitis

Prof. Dr. Dr. Katrin

2025 - 2026

CRIMSON: A multicentre, randomised, sham-controlled (andactive controlled in the USA), double-masked, 72-week trial tostudy the safety, tolerability, pharmacokinetics, and efficacy of3 dosing regimens of intravitreal BI 764524 in patients withmoderately severe to severe non-proliferative diabeticretinopathy

Prof. Dr. Dr. Katrin

2025

SEER-3: A Phase 3, Multi-Center, Randomized, Parallel, Double Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of Neurotrophic Keratopathy

PD Dr. Dr. Katrin

2025 - 2026

DX219

Prof. Dr. Dr. Katrin

2025 - 2026

A Phase 1b open-label, dose-escalating study evaluating the safety,tolerability, pharmacokinetics, and early signs of biological activity ofdanegaptide following oral administration in participants with diabeticmacular edema

Prof. Dr. Dr. Katrin

Klinikum

FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz

Starten Sie Ihre Suche...

Klinikum

FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz